MASI Quote, Financials, Valuation and Earnings

Boston Scientific Corp. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 12.68%. Masimo Corp.'s return on equity of 22.71% beat Boston Scientific Corp.'s return on equity of 12.55%.

Masimo Corp. has a consensus price target of $178.60, signalling upside risk potential of 1.81%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.24 which suggests that it could grow by 46.1%. Given that Boston Scientific Corp. has higher upside potential than Masimo Corp., analysts believe Boston Scientific Corp. is more attractive than Masimo Corp..

Masimo Corp. has a beta of 1.213, which suggesting that the stock is 21.291% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.688, suggesting its less volatile than the S&P 500 by 31.155%.

Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.

Masimo Corp. quarterly revenues are $412.5M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Masimo Corp.'s net income of $61.9M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Boston Scientific Corp.'s PE ratio is 36.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.18x versus 5.31x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical, Inc. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 17.01%. Masimo Corp.'s return on equity of 22.71% beat Globus Medical, Inc.'s return on equity of 12.49%.

Masimo Corp. has a consensus price target of $178.60, signalling upside risk potential of 1.81%. On the other hand Globus Medical, Inc. has an analysts' consensus of $109.54 which suggests that it could grow by 25.76%. Given that Globus Medical, Inc. has higher upside potential than Masimo Corp., analysts believe Globus Medical, Inc. is more attractive than Masimo Corp..

Masimo Corp. has a beta of 1.213, which suggesting that the stock is 21.291% more volatile than S&P 500. In comparison Globus Medical, Inc. has a beta of 1.048, suggesting its more volatile than the S&P 500 by 4.758%.

Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Globus Medical, Inc. pays out -- of its earnings as a dividend.

Masimo Corp. quarterly revenues are $412.5M, which are smaller than Globus Medical, Inc. quarterly revenues of $826.4M. Masimo Corp.'s net income of $61.9M is lower than Globus Medical, Inc.'s net income of $140.6M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Globus Medical, Inc.'s PE ratio is 22.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.18x versus 4.06x for Globus Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical, Inc. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 27.89%. Masimo Corp.'s return on equity of 22.71% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.

Masimo Corp. has a consensus price target of $178.60, signalling upside risk potential of 1.81%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $609.82 which suggests that it could grow by 24.41%. Given that Intuitive Surgical, Inc. has higher upside potential than Masimo Corp., analysts believe Intuitive Surgical, Inc. is more attractive than Masimo Corp..

Masimo Corp. has a beta of 1.213, which suggesting that the stock is 21.291% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.814%.

Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.

Masimo Corp. quarterly revenues are $412.5M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Masimo Corp.'s net income of $61.9M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Intuitive Surgical, Inc.'s PE ratio is 62.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.18x versus 17.67x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 12.96%. Masimo Corp.'s return on equity of 22.71% beat Insulet Corp.'s return on equity of 17.89%.

Masimo Corp. has a consensus price target of $178.60, signalling upside risk potential of 1.81%. On the other hand Insulet Corp. has an analysts' consensus of $354.40 which suggests that it could grow by 49.53%. Given that Insulet Corp. has higher upside potential than Masimo Corp., analysts believe Insulet Corp. is more attractive than Masimo Corp..

Masimo Corp. has a beta of 1.213, which suggesting that the stock is 21.291% more volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.422, suggesting its more volatile than the S&P 500 by 42.204%.

Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Masimo Corp. quarterly revenues are $412.5M, which are smaller than Insulet Corp. quarterly revenues of $783.8M. Masimo Corp.'s net income of $61.9M is lower than Insulet Corp.'s net income of $101.6M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Insulet Corp.'s PE ratio is 67.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.18x versus 6.26x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.